R&D Pipeline

Phase:

Therapy:

7 compounds matching your criteria
Compound/indication Phase 1 Phase 2 Phase 3 Filed
rFXIII Congenital deficiency

Haemostatic agent
rFVIII

Haemostatic agent
rFVIIa fast-acting analogue

Haemostatic agent
rFXIII Cardiac surgery

Haemostatic agent
rFVIIa long-acting derivative

Haemostatic agent
L.a rFIX derivative

Haemostatic agent
Sc l.a. rFVIIa derivative

Haemostatic agent
  •